NARA Discovery
Article Details
← Back to Search Results
Journal Article

A randomised, double-blind, placebo-controlled trial examining the dose-dependent effects of acute alcohol intoxication on neurocognitive performance

Blair Aitken; Brook Shiferaw; Luke A. Downey; Brooke Manning; Thomas Arkell; Michael G. Lenné; Jonny Kuo; Amie C. Hayley
Psychopharmacology · 2026

Abstract

Rationale Acute alcohol intoxication impairs cognitive and motor control, elevating risk in safety–critical contexts. While blood alcohol concentration (BAC) quantifies exposure, it does not reflect real-time functional impairment. Mobile, performance-based assessments may offer scalable detection tools, but their sensitivity under controlled alcohol challenge requires further validation. Objectives To evaluate the sensitivity of a mobile cognitive assessment (DRUID®) to alcohol-induced impairment across low and moderate intoxication levels and examined objective cognitive performance and subjective intoxication within a unified framework. Methods In a randomised, double-blind, placebo-controlled, within-subjects trial, 30 healthy adults (33% female; aged 23–49 years) completed neurocognitive testing following placebo, low-dose alcohol (mean peak BAC 0.04%), and moderate-dose alcohol (mean peak BAC 0.07%). Cognitive performance was measured using the Cambridge Neuropsychological Test Automated Battery (CANTAB) and DRUID®, while subjective effects were assessed via the Brief Biphasic Alcohol Effects Scale and a single-item intoxication rating. Results Moderate alcohol intoxication significantly impaired spatial working memory, sustained attention, and psychomotor control (all p < 0.05), and elevated DRUID® impairment scores at 130 min post-dose relative to placebo ( p < 0.001). Low-dose alcohol increased subjective intoxication and sedation (both p < 0.001) without measurable cognitive impairment. Conclusions Moderate alcohol produced persistent neurocognitive deficits despite dissociation between subjective and objective measures. Findings support performance-based impairment models and highlight mobile cognitive tools such as DRUID® as practical candidates for real-time functional assessment in applied safety settings. Trial registration ACTRN12623000528651, 19/05/2023.

Bibliographic Information

JournalPsychopharmacology
PublisherSpringer
Publication Date2026-05-14
Publication Year2026
Document TypeJournal Article
Print ISSN0033-3158
eISSN1432-2072
DOI10.1007/s00213-026-07090-z

Access Information

NARA Access Coverage1959-01-01~Current
Journal Homepagehttps://www.springer.com/journal/213
Publisher PageOpen Publisher Page
Full-text access depends on NARA's subscribed coverage and institutional access.